Beiley Biofund Inc. (TPEX:7882)
Taiwan · Delayed Price · Currency is TWD 28.50
+0.15 (0.53%)
At close: Oct 16, 2026
Beiley Biofund Revenue
Beiley Biofund had revenue of -246.77M TWD in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 905.49M, up 330.06% year-over-year. In the year 2025, Beiley Biofund had annual revenue of 1.23B with 773.27% growth. That makes Beiley Biofund the 31,801st largest company in the world by revenue and 1,629th in Taiwan.
Revenue (ttm)
905.49M
Revenue Growth
+330.06%
P/S Ratio
6.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23B | 1.09B | 773.27% |
| Dec 31, 2024 | 140.54M | 1.04M | 0.74% |
| Dec 31, 2023 | 139.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.